Menu

Image of the Day: Not All Bad

In zebrafish, some amount of reactive oxygen species is required for normal development.

Jul 16, 2018
Sukanya Charuchandra
The eye of a zebrafish embryo with an enlarged ganglion cell layer (green)
daniel suter/purdue uNiversity

Reactive oxygen species (ROS) levels are known to rise in times of stress or disease, leading to cellular damage, even going so far as cancer. However, ROS are needed to some extent for the formation of the nervous system in zebrafish, according to a study published in The Journal of Neuroscience on June 27.

In two separate experiments, researchers used a drug and CRISPR to shut down an enzyme known to produce ROS in zebrafish embryos. With both methods, they found an absence of the enzyme, meaning fewer ROS, led to defective visual signaling and other development. 

“We think there’s an ideal intermediate concentration [of ROS], but neither extreme is good,” coauthor Daniel Suter, a professor of biological sciences at Purdue University, says in a statement.

C.J. Weaver et al., “nox2/cybb deficiency affects zebrafish retinotectal connectivity,” J Neurosci, doi:10.1523/JNEUROSCI.1483-16.2018, 2018.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.